Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants

Artemisinin combination therapies are considered the mainstay of malaria treatment, but pediatric-friendly formulations for the treatment of infants are scarce. We sought to evaluate the efficacy and safety of a new dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate (DHA/PQP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargano, Nicola, Madrid, Lola, Valentini, Giovanni, D'Alessandro, Umberto, Halidou, Tinto, Sirima, Sodiomon, Tshefu, Antoinette, Mtoro, Ali, Gesase, Samwel, Bassat, Quique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740378/
https://www.ncbi.nlm.nih.gov/pubmed/29061746
http://dx.doi.org/10.1128/AAC.00596-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740378/
https://www.ncbi.nlm.nih.gov/pubmed/29061746
http://dx.doi.org/10.1128/AAC.00596-17

Ejemplares similares